{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T13:52:42Z","timestamp":1791035562153,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.medcli.2026.107545","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T16:29:36Z","timestamp":1787588976000},"page":"107545","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative efficacy and safety of rosuvastatin versus atorvastatin after acute ischemic stroke or transient ischemic attack: A systematic review and exploratory meta-analysis"],"prefix":"10.1016","volume":"166","author":[{"given":"Luis E.","family":"Cueva-Ca\u00f1ola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea C.","family":"Beltran-De la Fuente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana I.","family":"Ram\u00edrez Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid G.","family":"Carri\u00f3n-Cu\u00e9llar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno J.","family":"Navarro-Rondoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yerson","family":"Alberca-Naira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Mendoza Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold","family":"Jimenez-Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karoly P.","family":"Zu\u00f1iga-Monta\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erick N.","family":"Calvario-Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Rangel-Castilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2026.107545_bib0170","doi-asserted-by":"crossref","first-page":"102758","DOI":"10.1016\/j.eclinm.2024.102758","article-title":"Global, regional, and national burden of ischemic stroke, 1990\u20132021: an analysis of data from the global burden of disease study 2021","volume":"75","author":"Li","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.medcli.2026.107545_bib0175","doi-asserted-by":"crossref","first-page":"1567275","DOI":"10.3389\/fpubh.2025.1567275","article-title":"Global, regional, and national trends in ischaemic stroke burden and risk factors among adults aged 20+ years (1990\u20132021): a systematic analysis of data from the Global Burden of Disease study 2021 with projections into 2050","volume":"13","author":"Liu","year":"2025","journal-title":"Front Public Health"},{"key":"10.1016\/j.medcli.2026.107545_bib0180","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S1474-4422(21)00252-0","article-title":"Global, regional, and national burden of stroke and its risk factors, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"20","year":"2021","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.medcli.2026.107545_bib0185","doi-asserted-by":"crossref","first-page":"e279","DOI":"10.1212\/WNL.0000000000013115","article-title":"Global, regional, and national burden of ischemic stroke, 1990\u20132019","volume":"98","author":"Ding","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.medcli.2026.107545_bib0190","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1161\/STR.0000000000000475","article-title":"2024 guideline for the Primary Prevention of stroke: a guideline from the American Heart Association\/American stroke association","volume":"55","author":"Bushnell","year":"2024","journal-title":"Stroke"},{"key":"10.1016\/j.medcli.2026.107545_bib0195","doi-asserted-by":"crossref","first-page":"e364","DOI":"10.1161\/STR.0000000000000375","article-title":"2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American heart association\/American stroke association","volume":"52","author":"Kleindorfer","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.medcli.2026.107545_bib0200","doi-asserted-by":"crossref","first-page":"e41868","DOI":"10.1097\/MD.0000000000041868","article-title":"A comprehensive guide to conduct a systematic review and meta-analysis in medical research","volume":"104","author":"Calderon Martinez","year":"2025","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.medcli.2026.107545_bib0205","doi-asserted-by":"crossref","first-page":"195","DOI":"10.5195\/jmla.2020.834","article-title":"Improving the translation of search strategies using the Polyglot Search Translator: a randomized controlled trial","volume":"108","author":"Clark","year":"2020","journal-title":"J Med Libr Assoc"},{"key":"10.1016\/j.medcli.2026.107545_bib0210","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.medcli.2026.107545_bib0215","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.medcli.2026.107545_bib0220","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.4314\/tjpr.v16i10.26","article-title":"Effects of atorvastatin and rosuvastatin on blood lipids, platelet aggregation rate and inflammatory factors in patients with cerebral infarction","volume":"16","author":"Cao","year":"2017","journal-title":"Trop J Pharm Res"},{"key":"10.1016\/j.medcli.2026.107545_bib0225","doi-asserted-by":"crossref","first-page":"e038080","DOI":"10.1161\/JAHA.124.038080","article-title":"Comparative effectiveness of rosuvastatin versus atorvastatin in acute ischemic stroke treatment","volume":"14","author":"Kim","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.medcli.2026.107545_bib0230","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.62347\/GQIE8716","article-title":"Comparison of efficacy and safety between loading-dose atorvastatin and rosuvastatin in cerebral infarction","volume":"16","author":"Li","year":"2024","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.medcli.2026.107545_bib0235","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1177\/17474930231172623","article-title":"Is statin therapy after ischaemic stroke associated with increased intracerebral hemorrhage? The association may be dependent on intensity of statin therapy","volume":"18","author":"Yang","year":"2023","journal-title":"Int J Stroke"},{"key":"10.1016\/j.medcli.2026.107545_bib0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103381","article-title":"Comparative effectiveness and safety of atorvastatin versus rosuvastatin among patients with ischemic stroke or transient ischemic attack: a national registry-based observational study","volume":"86","author":"Zhao","year":"2025","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.medcli.2026.107545_bib0245","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2020.575678","article-title":"Pharmacogenetics of statin-induced myotoxicity","volume":"11","author":"Kee","year":"2020","journal-title":"Front Genet"},{"key":"10.1016\/j.medcli.2026.107545_bib0250","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.medcli.2026.107545_bib0255","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2174\/1570161116666180706144824","article-title":"Statins: pharmacokinetics, pharmacodynamics and cost-effectiveness analysis","volume":"17","author":"Ricci","year":"2019","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.medcli.2026.107545_bib0260","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1472-8206.2004.00299.x","article-title":"Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update","volume":"19","author":"Schachter","year":"2005","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.medcli.2026.107545_bib0265","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s00204-023-03492-6","article-title":"Understanding the molecular mechanisms of statin pleiotropic effects","volume":"97","author":"German","year":"2023","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.medcli.2026.107545_bib0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.jocn.2025.111361","article-title":"Intensive versus non-intensive statin therapy in patients with ischemic stroke: a systematic review and meta-analysis","volume":"138","author":"Costa","year":"2025","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.medcli.2026.107545_bib0275","doi-asserted-by":"crossref","first-page":"112","DOI":"10.5144\/0256-4947.2025.112","article-title":"High-dose statins for the prevention of recurrent ischemic stroke: a systematic review and meta-analysis of randomized controlled trials","volume":"45","author":"Shahid","year":"2025","journal-title":"Ann Saudi Med"},{"key":"10.1016\/j.medcli.2026.107545_bib0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.jocn.2026.111873","article-title":"Association between the cumulative defined daily dose of statins and ischemic stroke recurrence: a cohort study","volume":"146","author":"Han","year":"2026","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.medcli.2026.107545_bib0285","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3390\/neurolint17110176","article-title":"Impact of Statin Therapy on the risk of Stroke Recurrence, mortality, and Dementia After Ischemic Stroke (ISMARDD study): a comprehensive meta-analysis","volume":"17","author":"Gupta","year":"2025","journal-title":"Neurol Int"},{"key":"10.1016\/j.medcli.2026.107545_bib0290","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s00234-025-03583-4","article-title":"Impact of pretreatment and early treatment with statins on safety and efficacy outcomes in patients after acute ischemic stroke undergoing endovascular thrombectomy: a systematic review and meta-analysis","volume":"67","author":"Gon\u00e7alves","year":"2025","journal-title":"Neuroradiology"},{"key":"10.1016\/j.medcli.2026.107545_bib0295","article-title":"Risk of hematuria, proteinuria, and cardiovascular events in patients treated with rosuvastatin compared with atorvastatin: a retrospective cohort study in 136,680 patients","author":"Ghanshani","year":"2025","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.medcli.2026.107545_bib0300","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/14622416.2025.2547565","article-title":"The pharmacogenetics of rosuvastatin and implications for treatment: a systematic review","volume":"26","author":"Gonz\u00e1lez-Iglesias","year":"2025","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.medcli.2026.107545_bib0305","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3390\/jpm11030204","article-title":"SLCO1B1 phenotype and CYP3A5 polymorphism significantly affect atorvastatin bioavailability","volume":"11","author":"Zubiaur","year":"2021","journal-title":"J Pers Med"},{"key":"10.1016\/j.medcli.2026.107545_bib0310","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1186\/s12872-024-04142-0","article-title":"Assessing the effect of high-dose rosuvastatin in elderly patients over 75 with acute coronary syndrome","volume":"24","author":"Taherkhani","year":"2024","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.medcli.2026.107545_bib0315","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s12020-022-03263-w","article-title":"Statin intolerance management: a systematic review","volume":"79","author":"Meza-Contreras","year":"2023","journal-title":"Endocrine"},{"key":"10.1016\/j.medcli.2026.107545_bib0320","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.jare.2024.12.020","article-title":"Advances in statin adverse reactions and the potential mechanisms: a systematic review","volume":"76","author":"Zeng","year":"2025","journal-title":"J Adv Res"},{"key":"10.1016\/j.medcli.2026.107545_bib0325","series-title":"Statins: Drug Safety Communication \u2013 FDA Requests Removal of Strongest Warning Against Using Cholesterol-lowering Statins During Pregnancy","year":"2024"},{"key":"10.1016\/j.medcli.2026.107545_bib0330","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/1753-0407.12610","article-title":"Regional evidence and international recommendations to guide lipid management in Asian patients with type 2 diabetes with special reference to renal dysfunction","volume":"10","author":"Lau","year":"2018","journal-title":"J Diabetes"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775326001958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775326001958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T12:56:45Z","timestamp":1791032205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775326001958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0025775326001958"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2026.107545","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative efficacy and safety of rosuvastatin versus atorvastatin after acute ischemic stroke or transient ischemic attack: A systematic review and exploratory meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2026.107545","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107545"}}